Aaron Kramer
Algemeen Directeur bij Trygg Pharma AS
Profiel
Aaron Kramer is currently the Chief Executive Officer at Trygg Pharma AS.
Previously, he was the President-Pharmaceutical at Aker BioMarine ASA in 2010.
He holds an MBA from Harvard University and an undergraduate degree from Tufts University.
Actieve functies van Aaron Kramer
| Bedrijven | Functie | Begin |
|---|---|---|
Trygg Pharma AS
 Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Trygg Pharma AS develops marine based omega-3 fatty acids for pharmaceutical applications. Its products consist of AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters; and AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters. The company was founded in 2009 and is headquartered in Oslo, Norway. | Algemeen Directeur | - |
Eerdere bekende functies van Aaron Kramer
| Bedrijven | Functie | Einde |
|---|---|---|
Aker BioMarine ASA
 Aker BioMarine ASA Agricultural Commodities/MillingProcess Industries Aker BioMarine ASA engages in the marine biotechnology industry. It develops and supplies biomarine ingredients to the animal, human nutrition, and pharmaceutical markets. Its core business is harvesting, production, sales and marketing of krill based products. The company was founded in 2006 and is headquartered in Oslo, Norway. | Financieel Directeur/CFO | 11-06-2010 |
Opleiding van Aaron Kramer
| Tufts University | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Aker BioMarine ASA
Aker BioMarine ASA Agricultural Commodities/MillingProcess Industries Aker BioMarine ASA engages in the marine biotechnology industry. It develops and supplies biomarine ingredients to the animal, human nutrition, and pharmaceutical markets. Its core business is harvesting, production, sales and marketing of krill based products. The company was founded in 2006 and is headquartered in Oslo, Norway. | Process Industries |
Trygg Pharma AS
Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Trygg Pharma AS develops marine based omega-3 fatty acids for pharmaceutical applications. Its products consist of AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters; and AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters. The company was founded in 2009 and is headquartered in Oslo, Norway. | Health Technology |
